Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220975835> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4220975835 endingPage "24" @default.
- W4220975835 startingPage "24" @default.
- W4220975835 abstract "PURPOSE: The healthcare industry’s efforts to immunize the global community against SARS-CoV-2 are unprecedented. Given vaccine fast-tracking, its medical implications remain largely unknown in many populations. This study aims to analyze post-operative outcomes in SARS-CoV-2-vaccinated microsurgery patients to ascertain its potential protective effects using a federated electronic medical record network (TriNetX Inc, Cambridge,MA). METHODS: After screening 70 million de-identified records, 16,799 microsurgery patients meeting criteria were allocated into two cohorts using medical coding. Cohort One received SARS-CoV-2-vaccination prior to undergoing microsurgery whereas Cohort Two did not. Two equal sized cohorts, totaling 818 patients were created following propensity score matching for characteristics including: age, race/ethnicity, smoking, hypertension, heart disease, diabetes, obesity, chronic obstructive pulmonary disease, and history of SARS-CoV-2 exposure. Postoperative outcomes within 30,60, and 90-days of microsurgery were analyzed. RESULTS: Patients who were SARS-CoV-2-immunized experienced significantly fewer(p<0.01) surgical site infections (Absolute Risk Reduction(ARR)[95%CI])=(3.79-5.36%[0.84-8.54]), ICU admission(9.47-9.82%[5.45-13.88]), infections(7.68-9.92%[3.15-14.64]), and hospitalizations(28.48-32.57%[20.99-40.13]) within 30,60, and 90-days of microsurgery. Vaccinated patients also experienced significantly less flap failure(2.49%[0.97-4.02] and death(2.46%[0.96-3.97]) within 30 and 60-days post-operatively. CONCLUSION: Our analysis explores the potential protective effect of SARS-CoV-2-vaccination in microsurgical patients. Limitations include the retrospective nature and reliance on accuracy of medical coding of our study. Future prospective randomized control trials are warranted to better understand if in fact pre-operative SARS-CoV-2- vaccination has the potential to protect against post-operative microsurgery outcomes." @default.
- W4220975835 created "2022-04-03" @default.
- W4220975835 creator A5000295358 @default.
- W4220975835 creator A5021250097 @default.
- W4220975835 creator A5031913009 @default.
- W4220975835 creator A5032672394 @default.
- W4220975835 creator A5066201258 @default.
- W4220975835 creator A5071018353 @default.
- W4220975835 date "2022-04-01" @default.
- W4220975835 modified "2023-09-26" @default.
- W4220975835 title "47. THE IMPACT OF SARS-COV-2 VACCINATION ON POST-OPERATIVE OUTCOMES IN 818 MICROSURGERY PATIENTS: A MULTICENTER ANALYSIS" @default.
- W4220975835 doi "https://doi.org/10.1097/01.gox.0000828176.00260.42" @default.
- W4220975835 hasPublicationYear "2022" @default.
- W4220975835 type Work @default.
- W4220975835 citedByCount "0" @default.
- W4220975835 crossrefType "journal-article" @default.
- W4220975835 hasAuthorship W4220975835A5000295358 @default.
- W4220975835 hasAuthorship W4220975835A5021250097 @default.
- W4220975835 hasAuthorship W4220975835A5031913009 @default.
- W4220975835 hasAuthorship W4220975835A5032672394 @default.
- W4220975835 hasAuthorship W4220975835A5066201258 @default.
- W4220975835 hasAuthorship W4220975835A5071018353 @default.
- W4220975835 hasBestOaLocation W42209758351 @default.
- W4220975835 hasConcept C126322002 @default.
- W4220975835 hasConcept C141071460 @default.
- W4220975835 hasConcept C142724271 @default.
- W4220975835 hasConcept C17923572 @default.
- W4220975835 hasConcept C195910791 @default.
- W4220975835 hasConcept C201903717 @default.
- W4220975835 hasConcept C22070199 @default.
- W4220975835 hasConcept C2779134260 @default.
- W4220975835 hasConcept C2781437307 @default.
- W4220975835 hasConcept C71924100 @default.
- W4220975835 hasConcept C72563966 @default.
- W4220975835 hasConceptScore W4220975835C126322002 @default.
- W4220975835 hasConceptScore W4220975835C141071460 @default.
- W4220975835 hasConceptScore W4220975835C142724271 @default.
- W4220975835 hasConceptScore W4220975835C17923572 @default.
- W4220975835 hasConceptScore W4220975835C195910791 @default.
- W4220975835 hasConceptScore W4220975835C201903717 @default.
- W4220975835 hasConceptScore W4220975835C22070199 @default.
- W4220975835 hasConceptScore W4220975835C2779134260 @default.
- W4220975835 hasConceptScore W4220975835C2781437307 @default.
- W4220975835 hasConceptScore W4220975835C71924100 @default.
- W4220975835 hasConceptScore W4220975835C72563966 @default.
- W4220975835 hasIssue "4S" @default.
- W4220975835 hasLocation W42209758351 @default.
- W4220975835 hasLocation W42209758352 @default.
- W4220975835 hasLocation W42209758353 @default.
- W4220975835 hasOpenAccess W4220975835 @default.
- W4220975835 hasPrimaryLocation W42209758351 @default.
- W4220975835 hasRelatedWork W1918795463 @default.
- W4220975835 hasRelatedWork W2003938723 @default.
- W4220975835 hasRelatedWork W2047967234 @default.
- W4220975835 hasRelatedWork W2118496982 @default.
- W4220975835 hasRelatedWork W2384980663 @default.
- W4220975835 hasRelatedWork W2439875401 @default.
- W4220975835 hasRelatedWork W2999114503 @default.
- W4220975835 hasRelatedWork W3092529470 @default.
- W4220975835 hasRelatedWork W3125815157 @default.
- W4220975835 hasRelatedWork W2525756941 @default.
- W4220975835 hasVolume "10" @default.
- W4220975835 isParatext "false" @default.
- W4220975835 isRetracted "false" @default.
- W4220975835 workType "article" @default.